Hyperglycemia Identified as Rare Cause of Quadriplegia in Osmotic Demyelination Syndrome: Case Study
India: A recent case report published in the Journal of the Association of Physicians of India has highlighted hyperglycemia ...
or hyperglycemic hyperosmolar syndrome (HHS). Long-term complications include heart disease and stroke, diabetic neuropathy (nerve damage), kidney disease, foot problems, eye disease, gum disease ...
Hosted on MSN15d
What is a Dangerous Blood Sugar Level?Diabetic ketoacidosis (DKA) and hyperglycemic hyperosmolar nonketotic syndrome (HHNS) or hyperglycemic hyperosmolar nonketotic coma (HHNKC) are diabetes emergencies that occur when blood sugars ...
Diabetic ketoacidosis (DKA) and hyperglycemic hyperosmolar nonketotic syndrome (HHNS) or hyperglycemic hyperosmolar nonketotic coma (HHNKC) are diabetes emergencies that occur when blood sugars are at ...
Elevated blood sugar can also cause acute conditions, such as diabetic ketoacidosis (more common in people with type 1 diabetes) or hyperglycemic hyperosmolar nonketotic syndrome (more common in ...
Non-alcoholic fatty liver disease can be accurately diagnosed by looking at a person’s gut microbiome signatures, scientists have said. Researchers can now predict if someone is at risk of developing ...
Good blood pressure control can prevent “major cardiovascular events” among people living with type 2 diabetes, a new study has claimed. Researchers from the UT Southwestern Medical Center have found ...
Uncontrolled Diabetes Side Effects: What Happens In Your Body When Blood Sugar Levels Hit 500 mg/dL?
A blood sugar level of 500 mg/dL or higher is considered dangerously high and is classified as hyperglycemia. This condition can even make it difficult for the heart and kidneys to function ...
and hyperglycemic hyperosmolar state (HHS) are fairly common and represent very challenging clinical management in practice. DKA and HHS are associated with high mortality rates if left not treated.
NEW BRUNSWICK, N.J. and BEDMINSTER, N.J., Jan. 13, 2025 (GLOBE NEWSWIRE) -- Johnson & Johnson (NYSE: JNJ) and Intra-Cellular Therapies, Inc. (Nasdaq: ITCI) announced ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results